Tag: withdrawal

Together, we can create a new way to support patients tapering psychiatric medications and the medically orphaned will finally feel welcomed.

Past research has framed symptom increases during tapering and discontinuation of psychotropic drugs as a relapse of an underlying “illness.” A new preprint article...

This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported biological beliefs about mental "illness," and research linking...

In this conversation, Jan DeFehr argues that ethical practice requires access to what the field itself disputes, including the risks people rarely hear about.

Researchers found that for many doctors, renewing antidepressant prescriptions feels safer and faster than helping people taper, and that most current interventions fail to address the pressures driving that choice.

Maybe you have this interpretation that you're not going to recover and you have permanent damage, but it's not like that. I'm very hopeful.

A new study in Health Expectations led by Trinity College Dublin researchers finds that people withdrawing from psychiatric medications often endure severe symptoms, limited clinical support, and widespread uncertainty about how to taper safely.

Therapist and coach Nelson Lee joins us on the podcast to discuss how he approaches helping clients while navigating the complexities of antidepressant withdrawal.

I have been on Cymbalta for 17 years now and am gutted that my five-year taper did not free me of the drug.

Mental health nursing has a key role to play in helping people discontinue the drugs, writes Timothy Wand.

Drug-first treatment overlooks the underlying circumstances that contributed to the development of mental health issues in the first place.

A new study published in Psychology and Psychotherapy: Theory, Research and Practice finds that psychiatrists and other doctors are the most unhelpful factor for...

A new study, published in Molecular Psychiatry, investigates the prevalence and typical characteristics of antidepressant withdrawal syndrome (AWS) through analyzing available research. Researchers found...

A new commentary published in Current Opinion in Psychiatry presents the case for slow tapering of antipsychotics. According to authors Mark Horowitz and Joanna...

A response to a seriously flawed review.

The medications are there to disconnect us from our divine, creative Self, but the human being is remarkable and incredibly resilient.

This is the story of a young woman who suffered through the agony of "kindling" and other drug-related harm, eventually dying by suicide. This is also the story of her mother’s path ahead.

Tapering should be tailored and adjusted to the patient, slowed and more hyperbolic in people who have severe and longstanding reactions.

Ayurdhi Dhar interviews psychiatrist Swapnil Gupta on psychiatric drug discontinuation, drug cocktail risks, patient choice, and the need for trust and transparency.

New research finds that the non-physical aspects of withdrawal from SSRIs are often overlooked.

Antidepressant users share their frustrations towards a healthcare system that overprescribes but is ill-equipped to support with discontinuation and withdrawal symptoms.

Researchers find that adverse effects often last over a year, with many users experiencing substantial life changes.

Growing rates of long-term psychiatric drug prescriptions and documented issues with withdrawal demonstrate a need for safe deprescribing practices.

New guidance for primary care doctors in the UK on antidepressant discontinuation acknowledges severe and long-lasting withdrawal symptoms.

A new literature review reinforces the need to “down-titrate” or taper antidepressants, especially drugs like Celexa and Paxil.